Author information:
(1)From the Division of Rheumatology, Department of Medicine, Medical University 
of Vienna, Vienna, Austria; Division of Immunology and Rheumatology, Stanford 
University Medical Center, Palo Alto, California, USA; Division of Rheumatology, 
Department of Internal Medicine, Keio University, Tokyo, Japan; Lilly Research 
Laboratories, Eli Lilly and Co., Indianapolis, Indiana, USA; Lilly Research 
Laboratories, Eli Lilly and Co., Kobe, Japan; Oregon Health Sciences University, 
Portland, Oregon, USA. josef.smolen@meduniwien.ac.at.
(2)J.S. Smolen, MD, Division of Rheumatology, Department of Medicine, Medical 
University of Vienna; M.C. Genovese, MD, Division of Immunology and 
Rheumatology, Stanford University Medical Center; T. Takeuchi, MD, PhD, Division 
of Rheumatology, Department of Internal Medicine, Keio University; D.L. Hyslop, 
MD, Lilly Research Laboratories, Eli Lilly and Co., USA; W. Macias, MD, PhD, 
Lilly Research Laboratories, Eli Lilly and Co., USA; T. Rooney, MD, Lilly 
Research Laboratories, Eli Lilly and Co., USA; L. Chen, MD, PhD, Lilly Research 
Laboratories, Eli Lilly and Co., USA; C.L. Dickson, BS Pharm, Lilly Research 
Laboratories, Eli Lilly and Co., USA; J. Riddle Camp, BA, Lilly Research 
Laboratories, Eli Lilly and Co., USA; T.E. Cardillo, MSN, Lilly Research 
Laboratories, Eli Lilly and Co., USA; T. Ishii, MD, PhD, Lilly Research 
Laboratories, Eli Lilly and Co., Japan; K.L. Winthrop, MD, MPH, Oregon Health 
Sciences University. josef.smolen@meduniwien.ac.at.
(3)From the Division of Rheumatology, Department of Medicine, Medical University 
of Vienna, Vienna, Austria; Division of Immunology and Rheumatology, Stanford 
University Medical Center, Palo Alto, California, USA; Division of Rheumatology, 
Department of Internal Medicine, Keio University, Tokyo, Japan; Lilly Research 
Laboratories, Eli Lilly and Co., Indianapolis, Indiana, USA; Lilly Research 
Laboratories, Eli Lilly and Co., Kobe, Japan; Oregon Health Sciences University, 
Portland, Oregon, USA.
(4)J.S. Smolen, MD, Division of Rheumatology, Department of Medicine, Medical 
University of Vienna; M.C. Genovese, MD, Division of Immunology and 
Rheumatology, Stanford University Medical Center; T. Takeuchi, MD, PhD, Division 
of Rheumatology, Department of Internal Medicine, Keio University; D.L. Hyslop, 
MD, Lilly Research Laboratories, Eli Lilly and Co., USA; W. Macias, MD, PhD, 
Lilly Research Laboratories, Eli Lilly and Co., USA; T. Rooney, MD, Lilly 
Research Laboratories, Eli Lilly and Co., USA; L. Chen, MD, PhD, Lilly Research 
Laboratories, Eli Lilly and Co., USA; C.L. Dickson, BS Pharm, Lilly Research 
Laboratories, Eli Lilly and Co., USA; J. Riddle Camp, BA, Lilly Research 
Laboratories, Eli Lilly and Co., USA; T.E. Cardillo, MSN, Lilly Research 
Laboratories, Eli Lilly and Co., USA; T. Ishii, MD, PhD, Lilly Research 
Laboratories, Eli Lilly and Co., Japan; K.L. Winthrop, MD, MPH, Oregon Health 
Sciences University.